David Karambizi

Executive Officer, Director at Tinos Therapeutics.

Raised on Tinos Therapeutics filings

$2.3M

of $4M offered across 1 Form D filing

Company

Biotech · Cambridge, MA

RNA-targeted small-molecule drugs for glioblastoma

RNA-targeted small-molecule drugs for glioblastoma

Tinos Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Apr 17, 2026	Option to acquire	$2.3M/ $4M	Form D/A

Also named on Tinos Therapeutics filings